echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > Antibiotic-Dietary Supplement Combination Improves Cognitive Ability in Mouse Model of Dementia

    Antibiotic-Dietary Supplement Combination Improves Cognitive Ability in Mouse Model of Dementia

    • Last Update: 2022-01-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Research by scientists from the Graduate School of Medicine at Osaka City University has shown that combining the generic antibiotic rifampicin with the dietary supplement resveratrol, intranasal administration may prevent neurodegenerative diseases (such as Alzheimer's disease) A feasible method


    Research leader Dr.


    Neurodegenerative dementias include Alzheimer's disease (AD), frontotemporal dementia (FTD) and dementia with Lewy bodies (DLB)


    Despite the "active efforts" made by researchers and pharmaceutical companies, there is no effective treatment for neurodegenerative dementia


    The newly reported study builds on the team’s previous experiments on mice.


    However, oral rifampicin is associated with side effects such as liver damage and drug-drug interactions


    The team also wants to identify potential compounds that may help ensure the long-term safety of rifampicin for nasal use


    Resveratrol is a natural antioxidant in plants and is widely used as a dietary supplement


    In their latest report, the research team used a fixed dose of rifampicin and resveratrol intranasally injected 5 days a week for 4 weeks to give patients with Alzheimer’s disease, frontotemporal dementia and Lewy small A mouse model of physical dementia


    The combination of the generic drug rifampicin and the dietary supplement resveratrol, as well as the use of nasal sprays in the nose, can prevent dementia more safely and effectively


    According to the team’s previous research experience, nasal administration of a fixed-dose combination of rifampicin and resveratrol can increase the transfer of the drug to the brain, further improving safety and medicinal effects


    Encouragingly, both drugs are cheap


    “The number of people with dementia around the world has been increasing, and some sources predict that the number of people with dementia will double every 20 years


    The author admits that further research is needed to determine the appropriate ratio of the two drugs, while conducting pharmacokinetic and general toxicity studies


    Medilabo RFP is currently developing a fixed-dose combination of rifampicin and resveratrol nasal spray


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.